Total Funding
33
54
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
180297
NTrans Technologies offers a proprietary platform technology for the intracellular delivery of bioactive molecules.
- Marco De Boer: CEO and Co-Founder
About the Company
NTrans Technologies offers a proprietary platform technology for the intracellular delivery of bioactive molecules.
The company is further developing this technology for both research and clinical purposes as a method for the delivery of biologicals that is safe, non-toxic, highly efficient, and easy to use. NTrans Technologies' goal is to be
a leader in technologies for the transduction of proteins and other bioactive molecules into primary cells.
